Arix Bioscience PLC
LSE:ARIX
Arix Bioscience PLC
LSE:ARIX
Price:
142 GBX
Market Closed
Updated:
May 5, 2024
Arix Bioscience PLC
Cash from Financing Activities
|
Arix Bioscience PLC
Cash from Financing Activities Peer Comparison
Comparables:
JHG
III
SDR
ICP
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arix Bioscience PLC
LSE:ARIX
|
Cash from Financing Activities
-£63k
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Cash from Financing Activities
-$151.9m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Cash from Financing Activities
-£490m
|
CAGR 3-Years
-157%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
|
Schroders PLC
LSE:SDR
|
Cash from Financing Activities
-£479.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Intermediate Capital Group PLC
LSE:ICP
|
Cash from Financing Activities
-£441.9m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Arix Bioscience PLC's Cash from Financing Activities?
Cash from Financing Activities
-63k
GBP
-63k
GBP
Based on the financial report for Dec 31, 2022, Arix Bioscience PLC's Cash from Financing Activities amounts to -63k GBP.
What is Arix Bioscience PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
60%
60%
Over the last year, the Cash from Financing Activities growth was 99%. The average annual Cash from Financing Activities growth rates for Arix Bioscience PLC have been 60% over the past three years .
You don't have any saved screeners yet
